Fr. 309.70

Macrocycles in Drug Discovery

English · Hardback

Shipping usually within 3 to 5 weeks (title will be specially ordered)

Description

Read more

Informationen zum Autor Jeremy Levin is currently a Director of Medicinal Chemistry at Boehringer Ingelheim Pharmaceuticals, with a total of 25 years of experience in the pharmaceutical industry. He has worked in multiple therapeutic areas, including CNS, inflammation and immunology, and oncology. Dr Levin has authored or co-authored more than 70 papers in peer reviewed journals and served as an inventor on more than 60 issued U.S patents. Klappentext This book reviews macrocycles in drug discovery, both those of natural origin and semi-synthetic derivatives of natural products, and those designed and synthesized based on principles of medicinal chemistry. The medicinal chemistry of macrocyclic natural products is interesting in itself, but lessons learned from these compounds, in terms of the relationship between structure and desirable physicochemical properties, are now informing the design of fully synthetic macrocyclic drug candidates against a variety of targets including kinases, ATPases, proteases, GPCRs and others. Furthermore, as more non-classical drug targets, such as protein-protein interactions, are pursued in the pharmaceutical industry, macrocyclic molecules are generating increasing interest as they offer a way to provide drug-protein interactions that cover a larger surface area than traditional small molecules.A variety of macrocycles have become important drugs or have been identified as leads to marketed drugs. This text will discuss these compounds, their pharmacology and synthesis, in the context of their broad chemotype as compounds composed of large rings. Providing a wide reaching review of this important area in a single volume, this book will be of interest to biochemists, pharmaceutical scientists and medicinal chemists working in industry or academia. Zusammenfassung This series provides a comprehensive resource for postgraduate students and for scientists in academia or industry wanting to learn topics outside their own areas of expertise. Inhaltsverzeichnis Introduction; Bioactive Macrocycles from Nature; Recent Advances in Macrocyclic Hsp90 Inhibitors; Epothilones; Macrocyclic Inhibitors of Zinc-dependent Histone Deacetylases (HDACs); Designed Macrocyclic Kinase Inhibitors; Anti-Inflammatory Macrolides to Manage Chronic Neutrophilic Inflammation; Linear and Macrocyclic Hepatitis C Virus Protease Inhibitors; Macrocyclic Inhibitors of GPCR's, Integrins and Protein-Protein Interactions; Macrocyclic a-Helical Peptide Drug Discovery; Optimizing the Permeability and Oral Bioavailability of Macrocycles; The Synthesis of Macrocycles for Drug Discovery...

Product details

Authors Jeremy Levin, Jeremy (Boehringer Ingelheim Levin
Assisted by Jeremy Levin (Editor), Jeremy (Boehringer Ingelheim Levin (Editor), David Rotella (Editor)
Publisher Royal Society Of Chemistry
 
Languages English
Product format Hardback
Released 16.10.2014
 
EAN 9781849737012
ISBN 978-1-84973-701-2
No. of pages 468
Series RSC Drug Discovery
Drug Discovery
Drug Discovery
RSC Drug Discovery
Subject Natural sciences, medicine, IT, technology > Medicine > Pharmacy

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.